Page 2 - Yong Zu Kim News Today : Breaking News, Live Updates & Top Stories | Vimarsana

LegoChem Biosciences Inc : LegoChemBio Signs License Agreement to Acquire First-in-class Antibody From Elthera

Preclinical results demonstrate the differentiation in efficacy and safety of this first-in-class candidate LegoChemBio to advance this potentially fifth LegoChemBio platform-generated ADC

Daeyoung jeongLegochem biosciencesLegochembio conjuallJanne schmidtEuropean union horizonEuropean unionSwiss innovation agencyLegochem biosciences incChem biosciencesYong zu kimInnosuisse swiss innovation agencyMarcel torney

SOTIO Exercises Option for Novel Antibody-Drug Conjugate Program under Agreement with LegoChem Biosc

SOT106 is an antibody-drug conjugate (ADC) targeting an attractive surface antigen expressed on multiple solid tumorsPreclinical efficacy and tolerability studies of SOT106 show promising results across multiple solid tumor indications and a beneficial therapeutic indexSOTIO is actively exploring additional tumor ta.

Czech republicLegochem biosciencesMichael tattoryRadek spisekRichard kapsaLifesci communicationsDrug developmentYong zu kimChem biosciencesMedical oncology

Investegate |SOTIO Biotech Announcements | SOTIO Biotech: SOTIO Exercises Option for Novel Antibody-Drug Conjugate Program under Agreement with LegoChem Biosciences

Investegate announcements from SOTIO Biotech, SOTIO Exercises Option for Novel Antibody-Drug Conjugate Program under Agreement with LegoChem Biosciences

Czech republicLegochem biosciencesMichael tattoryRadek spisekRichard kapsaLifesci communicationsDrug conjugate program under agreementNovel antibody drug conjugate programYong zu kimChem biosciencesInvestegate announcementsInvestegate company announcementsSotio biotechLobenewswire and globenewswire

SOTIO Exercises Option for Novel Antibody-Drug Conjugate Program under Agreement with LegoChem Biosciences

SOTIO Exercises Option for Novel Antibody-Drug Conjugate Program under Agreement with LegoChem Biosciences

Czech republicLegochem biosciencesMichael tattoryRadek spisekRichard kapsaLifesci communicationsDrug developmentYong zu kimChem biosciencesMedical oncologyAntibody drug conjugateLegochem biosciencesSolid tumors

NextCure and LegoChem Biosciences Enter into Collaboration and Co-Development Agreement to Develop Antibody Drug Conjugates

NextCure and LegoChem Biosciences Enter into Collaboration and Co-Development Agreement to Develop Antibody Drug Conjugates
forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.

Taejon gwangyoksiSouth koreaLegochem biosciencesTimothy mayerExchange commissionLegochem biosciences incNextcure incChief operatingYong zu kimChem biosciences